View more on these topics

Fidelity nurses healthcare

Fidelity Investments new Healthcare fund is a Luxemburg-domiciled Sicav and is a sub fund of a range of Fidelity funds.

Healthcare is aimed at experienced investors who are looking to invest in the general healthcare market and who are prepared to put up with medium to high levels of risk.

The fund will invest in companies around the world that are involved in the design, manufacture and sale of healthcare, biotechnology and medicine products, such as biotechnology company Genentech, which is researching heart attack and cancer drugs, and drug company Glaxo Wellcome. Its aim is to outperform the FTSE global health and FTSE global pharmaceutical indices.

Biotechnology is a growing area of the market, especially due to recent advances in cloning techniques. The increasing numbers of pensioners in developed countries are also having an affect on the healthcare and medicine markets as demand for drugs and treatments increases. This is a volatile field, because many companies involved in this area are often unable to take advantage of their discoveries due to huge development costs, but it can give high returns.

According to Standard & Poor’s the Fidelity funds international fund is ranked 38 out of 273 funds, based on £1,000 invested on a bid-to-bid basis, with gross income reinvested over three years to September 1, 2000.


Easier first step on to housing ladder

Affordability is returning to the housing market as young people find it easier to make their first mortgage payment than they did a decade ago.Research from Barclays Consumer Confidence Research shows house prices fell by 7 per cent in July compared with the same period a year ago.Although 54 per cent of owners expect the […]

Opening up annuities

Annuities and the open market option are getting unprecedented attention.Why are annuities and the open market option such political hot potatoes at the moment? If we are being frank, the word annuity sums up a heady combination of boredom and complexity which would send most politicians running to the House of Commons&#39 bars. Yet, annuities […]

Scottish Amicable Mortgage Protection – 8th September 2000

Type: Level or decreasing term assurance offering single or joint cover. Accident, sickness & unemployment cover and critical illness options available.Minimum premium: £5 a month, £50 a year.Minimum-maximum terms: 5-40 years.Charges: Policy fee £2.50 a month.Commission: Subject to negotiation.Contact:

LeggMason goes American

LeggMason Investors Asset Managers, formerly known as Johnson Fry, has brought in a new investment trust, called LeggMason investors American assets.The product, which will be listed on both the London and Channel Islands stock exchanges, is aimed at investors looking for both long-term growth and high income.The investment trust will focus primarily on America, with […]

Phone - thumbnail

Pension Wise — now taking calls…

Those with decent-length memories will recall that in the 2014 Budget statement George Osborne announced the new (and entirely unexpected) pension freedoms. The new rules come fully into force in less than two weeks.


News and expert analysis straight to your inbox

Sign up


    Leave a comment


    Why register with Money Marketing ?

    Providing trusted insight for professional advisers.  Since 1985 Money Marketing has helped promote and analyse the financial adviser community in the UK and continues to be the trusted industry brand for independent insight and advice.

    News & analysis delivered directly to your inbox
    Register today to receive our range of news alerts including daily and weekly briefings

    Money Marketing Events
    Be the first to hear about our industry leading conferences, awards, roundtables and more.

    Research and insight
    Take part in and see the results of Money Marketing's flagship investigations into industry trends.

    Have your say
    Only registered users can post comments. As the voice of the adviser community, our content generates robust debate. Sign up today and make your voice heard.

    Register now

    Having problems?

    Contact us on +44 (0)20 7292 3712

    Lines are open Monday to Friday 9:00am -5.00pm